Adaptive Radiotherapy for Lung Cancer

Seminars in Radiation Oncology

Volumn 20, Issue 2, 2010, Pages 94-106

  Sonke, Jan Jakob ^a   Belderbos, José ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADAPTIVE RADIOTHERAPY; ANATOMY; ARTICLE; BONY ANATOMY; BREATHING MECHANICS; CANCER RADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; DOSIMETRY; FLUOROSCOPY; FOUR DIMENSIONAL IMAGING; GEOMETRY; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; LUNG CANCER; LUNG TOXICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RANDOM ERROR; RISK REDUCTION; SYSTEMATIC ERROR; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME; UNCERTAINTY;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LUNG NEOPLASMS; MOVEMENT; PATIENT POSITIONING; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77249113832     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2009.11.003     Document Type: Article

References (124)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer. Cochrane Database Syst Rev (2000) CD002139
2. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, in IARC CancerBase (2004), IARC Press, Lyon, France
3. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
4. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
5. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 49 (2001) 23-33
6. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
7. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
8. Schaake-Koning C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
9. Auperin A., Rolland E., Curran W., et al. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs): A1-05. J Thorac Oncol 2 (2007) S310
10. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
11. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
12. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
13. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
14. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
15. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
16. Chapet O., Fraass B.A., and Ten Haken R.K. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 65 (2006) 255-265
17. Bradley J., Deasy J.O., Bentzen S., et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 1106-1113
18. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
19. Chapet O., Kong F.M., Lee J.S., et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77 (2005) 176-181
20. Schwarz M., Alber M., Lebesque J.V., et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 62 (2005) 561-570
21. van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 1121-1135
22. Erridge S.C., Seppenwoolde Y., Muller S.H., et al. Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol 66 (2003) 75-85
23. Jaffray D.A., Siewerdsen J.H., Wong J.W., et al. Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 1337-1349
24. Pouliot J., Bani-Hashemi A., Chen J., et al. Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys 61 (2005) 552-560
25. Mackie T.R., Balog J., Ruchala K., et al. Tomotherapy. Semin Radiat Oncol 9 (1999) 108-117
26. Bijhold J., Lebesque J.V., Hart A.A., et al. Maximizing setup accuracy using portal images as applied to a conformal boost technique for prostatic cancer. Radiother Oncol 24 (1992) 261-271
27. Leong J. Implementation of random positioning error in computerised radiation treatment planning systems as a result of fractionation. Phys Med Biol 32 (1987) 327-334
28. Valley J.F., and Mirimanoff R.O. Comparison of treatment techniques for lung cancer. Radiother Oncol 28 (1993) 168-173
29. Ketting C.H., Austin-Seymour M., Kalet I., et al. Automated planning target volume generation: An evaluation pitting a computer-based tool against human experts. Int J Radiat Oncol Biol Phys 37 (1997) 697-704
30. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
31. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015-1024
32. Grills I.S., Fitch D.L., Goldstein N.S., et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 334-341
33. Stroom J., Blaauwgeers H., van Baardwijk A., et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. Int J Radiat Oncol Biol Phys 69 (2007) 267-275
34. Marks L.B. A standard dose of radiation for "microscopic disease" is not appropriate. Cancer 66 (1990) 2498-2502
35. Withers H.R., Peters L.J., and Taylor J.M. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31 (1995) 353-359
36. Ekberg L., Holmberg O., Wittgren L., et al. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?. Radiother Oncol 48 (1998) 71-77
37. de Boer H.C., van Sornsen de Koste J.R., et al. Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planning. Int J Radiat Oncol Biol Phys 49 (2001) 857-868
38. Borst G.R., Sonke J.J., Betgen A., et al. Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. Int J Radiat Oncol Biol Phys 68 (2007) 555-561
39. Purdie T.G., Bissonnette J.P., Franks K., et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 68 (2007) 243-252
40. Sonke J.J., Rossi M., Wolthaus J., et al. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys 74 (2009) 567-574
41. Ross C.S., Hussey D.H., Pennington E.C., et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. Int J Radiat Oncol Biol Phys 18 (1990) 671-677
42. Seppenwoolde Y., Shirato H., Kitamura K., et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 822-834
43. Pantarotto J.R., Piet A.H., Vincent A., et al. Motion Analysis of 100 mediastinal lymph nodes: Potential pitfalls in treatment planning and adaptive strategies. Int J Radiat Oncol Biol Phys 74 (2009) 1092-1099
44. Balter J.M., Ten Haken R.K., Lawrence T.S., et al. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. Int J Radiat Oncol Biol Phys 36 (1996) 167-174
45. Nehmeh S.A., and Erdi Y.E. Respiratory motion in positron emission tomography/computed tomography: A review. Semin Nucl Med 38 (2008) 167-176
46. Engelsman M., Damen E.M., De Jaeger K., et al. The effect of breathing and set-up errors on the cumulative dose to a lung tumor. Radiother Oncol 60 (2001) 95-105
47. Wulf J., Hadinger U., Oppitz U., et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 57 (2000) 225-236
48. Chang J., Mageras G.S., Yorke E., et al. Observation of interfractional variations in lung tumor position using respiratory gated and ungated megavoltage cone-beam computed tomography. Int J Radiat Oncol Biol Phys 67 (2007) 1548-1558
49. Hugo G.D., Yan D., and Liang J. Population and patient-specific target margins for 4D adaptive radiotherapy to account for intra- and inter-fraction variation in lung tumour position. Phys Med Biol 52 (2007) 257-274
50. Sonke J.J., Lebesque J., and van Herk M. Variability of four-dimensional computed tomography patient models. Int J Radiat Oncol Biol Phys 70 (2008) 590-598
51. Hugo G., Vargas C., Liang J., et al. Changes in the respiratory pattern during radiotherapy for cancer in the lung. Radiother Oncol 78 (2006) 326-331
52. Purdie T.G., Moseley D.J., Bissonnette J.P., et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in stereotactic lung radiation therapy. Acta Oncol 45 (2006) 915-922
53. Ford E.C., Mageras G.S., Yorke E., et al. Respiration-correlated spiral CT: A method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med Phys 30 (2003) 88-97
54. Vedam S.S., Keall P.J., Kini V.R., et al. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol 48 (2003) 45-62
55. Low D.A., Nystrom M., Kalinin E., et al. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing. Med Phys 30 (2003) 1254-1263
56. Sonke J.J., Zijp L., Remeijer P., et al. Respiratory correlated cone beam CT. Med Phys 32 (2005) 1176-1186
57. Keall P.J., Mageras G.S., Balter J.M., et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 33 (2006) 3874-3900
58. Li T., Koong A., and Xing L. Enhanced 4D cone-beam CT with inter-phase motion model. Med Phys 34 (2007) 3688-3695
59. Zeng R., Fessler J.A., and Balter J.M. Estimating 3-D respiratory motion from orbiting views by tomographic image registration. IEEE Trans Med Imaging 26 (2007) 153-163
60. Wolthaus J.W., Sonke J.J., van Herk M., et al. Reconstruction of a time-averaged midposition CT scan for radiotherapy planning of lung cancer patients using deformable registration. Med Phys 35 (2008) 3998-4011
61. Rit S., Wolthaus J.W., van Herk M., et al. On-the-fly motion-compensated cone-beam CT using an a priori model of the respiratory motion. Med Phys 36 (2009) 2283-2296
62. Wolthaus J.W., Schneider C., Sonke J.J., et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys 65 (2006) 1560-1571
63. International Commission on Radiation Units and Measurements. ICRU Report 50. Prescribing, recording and reporting photo beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda, MD
64. International Commission on Radiation Units and Measurements. ICRU Report 62. Prescribing, recording and reporting photo beam therapy (supplement to ICRU Report 50) (1999), International Commission on Radiation Units and Measurements, Bethesda, MD
65. Antolak J.A., Rosen II C.C.H., Childress C.H., et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42 (1998) 661-672
66. Stroom J.C., Koper P.C., Korevaar G.A., et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol 51 (1999) 237-248
67. Craig T., Battista J., Moiseenko V., et al. Considerations for the implementation of target volume protocols in radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 241-250
68. Miller R.C., Bonner J.A., and Kline R.W. Impact of beam energy and field margin on penumbra at lung tumor-lung parenchyma interfaces. Int J Radiat Oncol Biol Phys 41 (1998) 707-713
69. Aaltonen P., Brahme A., Lax I., et al. Specification of dose delivery in radiation therapy. Recommendation by the Nordic Association of Clinical Physics (NACP). Acta Oncol 36 suppl 10 (1997) 1-32
70. Allen A.M., Siracuse K.M., Hayman J.A., et al. Evaluation of the influence of breathing on the movement and modeling of lung tumors. Int J Radiat Oncol Biol Phys 58 (2004) 1251-1257
71. Shih H.A., Jiang S.B., Aljarrah K.M., et al. Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 613-622
72. Underberg R.W., Lagerwaard F.J., Slotman B.J., et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 253-260
73. Rietzel E., Liu A.K., Chen G.T., et al. Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning. Int J Radiat Oncol Biol Phys 71 (2008) 1245-1252
74. Underberg R.W., Lagerwaard F.J., Slotman B.J., et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 62 (2005) 554-560
75. Lujan A.E., Larsen E.W., Balter J.M., et al. A method for incorporating organ motion due to breathing into 3D dose calculations. Med Phys 26 (1999) 715-720
76. McKenzie A.L. How should breathing motion be combined with other errors when drawing margins around clinical target volumes?. Br J Radiol 73 (2000) 973-977
77. Harsolia A., Hugo G.D., Kestin L.L., et al. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. Int J Radiat Oncol Biol Phys 70 (2008) 582-589
78. Liu H.H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279
79. Li J.G., and Xing L. Inverse planning incorporating organ motion. Med Phys 27 (2000) 1573-1578
80. Engelsman M., Remeijer P., van Herk M., et al. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer. Med Phys 30 (2003) 1086-1095
81. Zhang T., Jeraj R., Keller H., et al. Treatment plan optimization incorporating respiratory motion. Med Phys 31 (2004) 1576-1586
82. Chetty I.J., Rosu M., McShan D.L., et al. Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys 31 (2004) 925-932
83. Trofimov A., Rietzel E., Lu H.M., et al. Temporo-spatial IMRT optimization: Concepts, implementation and initial results. Phys Med Biol 50 (2005) 2779-2798
84. Li X., Zhang P., Mah D., et al. Novel lung IMRT planning algorithms with nonuniform dose delivery strategy to account for respiratory motion. Med Phys 33 (2006) 3390-3398
85. Mexner V., Wolthaus J.W., van Herk M., et al. Effects of respiration-induced density variations on dose distributions in radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 74 (2009) 1266-1275
86. Zhang P., Hugo G.D., and Yan D. Planning study comparison of real-time target tracking and four-dimensional inverse planning for managing patient respiratory motion. Int J Radiat Oncol Biol Phys 72 (2008) 1221-1227
87. Keall P.J., Joshi S., Vedam S.S., et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 32 (2005) 942-951
88. Löf J., Lind B.K., and Brahme A. An adaptive control algorithm for optimization of intensity modulated radiotherapy considering uncertainties in beam profiles, patient set-up and internal organ motion. Phys Med Biol 43 (1998) 1605-1628
89. Witte M.G., van der Geer J., and Schneider C. IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. Med Phys 34 (2007) 3544-3555
90. Ten Haken R.K., Balter J.M., Marsh L.H., et al. Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors. Int J Radiat Oncol Biol Phys 38 (1997) 613-617
91. Guckenberger M., Krieger T., Richter A., et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 91 (2009) 288-295
92. Kubo H.D., and Hill B.C. Respiration gated radiotherapy treatment: A technical study. Phys Med Biol 41 (1996) 83-91
93. Shirato H., Shimizu S., Shimizu T., et al. Real-time tumour-tracking radiotherapy. Lancet 353 (1999) 1331-1332
94. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44 (1999) 911-919
95. Adler Jr. J.R., Chang S.D., Murphy M.J., et al. The Cyberknife: A frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 69 (1997) 124-128
96. Casamassima F., Cavedon C., Francescon P., et al. Use of motion tracking in stereotactic body radiotherapy: Evaluation of uncertainty in off-target dose distribution and optimization strategies. Acta Oncol 45 (2006) 943-947
97. Korreman S.S., Juhler-Nottrup T., and Boyer A.L. Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance. Radiother Oncol 86 (2008) 61-68
98. Lin T., Cervino L.I., Tang X., et al. Fluoroscopic tumor tracking for image-guided lung cancer radiotherapy. Phys Med Biol 54 (2009) 981-992
99. Shirato H., Shimizu S., and Kunieda T. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1187-1195
100. Juhler Nottrup T., Korreman S.S., Pedersen A.N., et al. Intra- and interfraction breathing variations during curative radiotherapy for lung cancer. Radiother Oncol 84 (2007) 40-48
101. Chen Q.S., Weinhous M.S., and Deibel F.C. Fluoroscopic study of tumor motion due to breathing: Facilitating precise radiation therapy for lung cancer patients. Med Phys 28 (2001) 1850-1856
102. Keall P.J., Kini V.R., and Vedam S.S. Motion adaptive x-ray therapy: A feasibility study. Phys Med Biol 46 (2001) 1-10
103. Trofimov A., Vrancic C., Chan T.C., et al. Tumor trailing strategy for intensity-modulated radiation therapy of moving targets. Med Phys 35 (2008) 1718-1733
104. Yan D., Wong J., Vicini F., et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys 38 (1997) 197-206
105. Brock K.K., McShan D.L., Ten Haken R.K., et al. Inclusion of organ deformation in dose calculations. Med Phys 30 (2003) 290-295
106. Kessler M.L. Image registration and data fusion in radiation therapy. Br J Radiol 79 (2006) S99-S108
107. Unkelbach J., and Oelfke U. Incorporating organ movements in inverse planning: Assessing dose uncertainties by Bayesian inference. Phys Med Biol 50 (2005) 121-139
108. Lam K.L., Ten Haken R.K., Litzenberg D., et al. An application of Bayesian statistical methods to adaptive radiotherapy. Phys Med Biol 50 (2005) 3849-3858
109. Yan D., Wong J.W., Gustafson G., et al. A new model for "accept or reject" strategies in off-line and on-line megavoltage treatment evaluation. Int J Radiat Oncol Biol Phys 31 (1995) 943-952
110. Yan D., Jaffray D.A., and Wong J.W. A model to accumulate fractionated dose in a deforming organ. Int J Radiat Oncol Biol Phys 44 (1999) 665-675
111. van Zwienen M., van Beek S., Belderbos J., et al. Anatomical changes during radiotherapy of lung cancer patients. Int J Radiat Oncol Biol Phys 72 (2008) S111
112. Woodford C., Yartsev S., and Dar A.R.V. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys 69 (2007) 1316-1322
113. Feng M., Kong F.M., Gross M., et al. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 73 (2009) 1228-1234
114. Gillham C., Zips D., Ponisch F., et al. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?. Radiother Oncol 88 (2008) 335-341
115. Cohade C., and Wahl R.L. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 33 (2003) 228-237
116. van Loon J., Grutters J., Wanders R., et al. Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: A prospective study. Eur J Cancer 45 (2009) 588-595
117. Kased N., Erasmus J.J., Komaki R., et al. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: A brief review. J Thorac Oncol 3 (2008) 534-538
118. Yamamoto Y., Nishiyama Y., Monden T., et al. Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 33 (2006) 140-147
119. Aerts H.J., Bosmans G., van Baardwijk A.A., et al. Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: A prospective study. Int J Radiat Oncol Biol Phys 71 (2008) 1402-1407
120. De Ruysscher D., Houben A., Aerts H.J., et al. Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent radiation-induced lung toxicity (RILT): A prospective pilot study. Radiother Oncol 91 (2009) 415-420
121. Kong F.M., Frey K.A., Quint L.E., et al. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with nonsmall-cell lung cancer. J Clin Oncol 25 (2007) 3116-3123
122. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiother Oncol 82 (2007) 145-152
123. Erdi Y.E., Macapinlac H., Rosenzweig K.E., et al. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 27 (2000) 861-866
124. Yan D., Lockman D., Martinez A., et al. Computed tomography guided management of interfractional patient variation. Semin Radiat Oncol 15 (2005) 168-179